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Of the techniques available to both the clinician and the 
researcher, few are as widely employed as flow cytometry. 
With applications that range from common clinical lab-
oratory tests, such as complete blood count with differ-
ential and monitoring of CD4 cell count in HIV patients, 
to advanced, multicolor flow cytometry used to identify 
subtypes of inflammatory cells active in diseases such as 
psoriasis and lupus, flow cytometry has become rapid, 
flexible, and sensitive.
The FlOW cYTOmeTrY prOcess
Flow cytometry measures single cells “flowing” through 
a detector system. The process begins with the selection 
of fluorescent-labeled antibodies specific to cell-surface 
markers used to characterize the cell population of inter-
est. These cell surface markers are usually glycoproteins 
called cluster of differentiation (CD) markers, and they 
help differentiate cell subpopulations (e.g., CD3+CD8+ for 
cytotoxic T cells). Flow cytometry can be performed on a 
variety of tissues, including peripheral blood, bone mar-
row aspirates, skin biopsies, and tissue culture cell lines 
(Macey, 2007). The sample is processed, for example, 
with enzymatic degradation, centrifugation, and/or filtra-
tion to isolate the cells of interest, and the resulting cel-
lular suspension is “stained” with fluorescent antibodies. 
The single cell suspension is then introduced into the flow 
cytometer into a cell-free buffer solution called the sheath 
fluid, which flows toward a laser aimed at the solution’s 
path. Because the flow of the liquid through the tubing is 
laminar, or sheet-like, and the diameter of the tubing nar-
rows along its path, the cells are forced to line up single 
file as they approach the laser (Figure 1). The fluorescent 
chemical bound to the antibody, called a fluorophore, is 
chosen based on the specific wavelength of laser present 
in each flow cytometer. If cells have the selected mark-
er on the surface, the bound antibody–fluorophore will 
absorb the laser energy and subsequently release it in 
the form of a specific wavelength of light as the cells pass 
through the laser. The emitted light is detected by an opti-
cal system that is sensitive to various wavelengths, allow-
ing for information on multiple surface markers to be read 
simultaneously and collected by an adjoined computer. 
Specialized software then can graphically represent the 
distribution of the labeled cell populations in one-, two-, 
or three-dimensional formats (Figure 2).
A variety of fluorochromes are available that individu-
ally emit light of specific, different wavelengths while 
absorbing light of the same wavelength. This is the basis 
WHAT FLOW CYTOMETRY DOES
•  Flow cytometry is a sensitive, powerful method for 
simultaneously obtaining information on various 
cellular processes, including expression of surface 
markers, intracellular cytokine and signaling 
proteins, or cell cycle.
•  Flow cytometry measures these characteristics on 
each cell individually in a high-throughput fashion 
and excels in characterizing heterogeneous cell 
populations.
•  Flow cytometry is capable of sorting cells based on 
almost any of the features it measures.
LIMITATIONS
•  Flow cytometry is limited by its requirement 
that analyzed cells be in suspension, making 
information on tissue architecture and cell–cell 
interactions unavailable.
•  Cell subpopulations with similar marker expression 
are difficult to differentiate and analyses that 
employ more fluorophores are subject to signal 
spillover.
•  Flow cytometry may generate massive amounts of 
data, making analyses complicated.
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Figure 1. schematic representation of a flow cytometer. For details please see text. (1) Forward-scatter detector, (2) side-scatter detector, (3) fluorescence 
detector, (4) filters and mirrors, and (5) charged deflection plates.
Figure 2. scatter plots displaying the Fsc (X-axis) and ssc (Y-axis) of lysed whole peripheral blood. The FSC scatter data provide information on the relative 
size of the cells, whereas the SSC data estimate the granularity. Four ways of displaying identical data: (i) pseudocolor dot plot (allows simultaneous information 
of rare events (dots) and high-frequency areas with dots of different color), (ii) dot plot where each dot represents one event (note that here only 10,000 events 
are shown to avoid oversaturation of dots), (iii) 5% probability density plot, and (iv) 5% probability contour plot, where the density of a population is translated 
in varying shades of color or concentric rings of varying distance. Major leukocyte populations as defined by FSC and SSC properties are shown in (i). FSC-A, 
forward scatter area; RBC, red blood cells; SSC-A, side scatter area. 
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for polychromatic flow cytometry, and it allows for a flow 
cytometry sample labeled with different fluorochrome–
antibody complexes to be read simultaneously with one 
pass through the laser. Because emission spectra of fluo-
rochromes overlap to varying degrees, a single detector 
may see fluorescence originating from more than one 
fluorochrome; this spillover must be removed using a 
mathematical algorithm, so that one detector reports sig-
nal from only one fluorochrome. This process is called 
“compensation.”
In addition to antibodies, fluorescent dyes are available 
that label the plasma membrane, DNA, or, for example, 
substrates for enzymes (e.g., apoptosis-inducing cas-
pases or autophagy-related enzyme LC3). Thus, it is pos-
sible to simultaneously measure multiple parameters in a 
single cell by detecting cell-surface molecules defining 
the lineage (CD3+CD4+ T-cell lymphocytes), activation 
status (HLA-DR, CD38), phosphorylation status of signal 
transduction molecules (“phospho-flow”), intracellular 
cytokine production, cell cycle phase (via DNA content), 
viability, calcium flux, oxidative burst, etc.
FlOW cYTOmeTric cell sOrTinG, “FluOrescence-
acTiVaTed cell sOrTinG”
Cells of interest can be separated to very high purity (very 
often 99%) by cell-sorting flow cytometers. After cells 
are “interrogated” by laser light in the flow chamber, the 
single cell stream is broken accurately into tiny droplets 
by a fine nozzle vibrating at ultrasonic frequency. Very 
rapid computation of the signals elicited by the cell in the 
flow chamber makes it possible to deflect droplets car-
rying cells of interest using positive, neutral, or negative 
electric charges (Figure 1). The droplets enter an electro-
magnetic field and are pushed, based on their charge, 
into different sorting containers.
FlOW cYTOmeTrY daTa analYsis
In addition to the fluorescence data, optical information 
known as forward scatter (FSC) and side scatter (SSC) is 
obtained based on the angle of light emitted from the ana-
lyzed cell. Classically, FSC is light scattered at a small angle 
and detected by a sensor on the opposite side of the 488-
nm/blue laser source (Figure 1). FSC essentially provides 
information correlating with cell size. Light that scatters 
off the cell at a 90° angle, called “side-scatter,” is picked 
up by an adjacent series of sensors and provides informa-
tion on the granularity of the cell. This could be useful, for 
example, when trying to distinguish between lymphocytes 
and granulocytes. The scatter plot is one of the most basic 
means of visualizing flow cytometric data, and the informa-
tion is plotted with the X-axis as FSC intensity and the Y-axis 
as SSC intensity (Figure 2). The axes of the plots are labeled 
with the name of the fluorochrome and the surface marker 
(e.g., FITC–CD3 for fluorescein isothiocyanate–labeled CD3 
cells). Cells positive for both markers will be located in the 
upper right quadrant, whereas cells negative for both will be 
located in the bottom left quadrant (Figure 3). For the scatter 
dot plots the axes are linear, whereas in fluorescence plots, 
because of the wide range of fluorescence signals, they are 
usually displayed logarithmically (Herzenberg et al., 2006).
“Gating” is the term used to describe the selection of a sub-
population of cells for analysis. For example, if further char-
acterization of only lymphocytes within the white blood cells 
is desired, the region of the lymphocytes on the FSC–SSC plot 
would be outlined and a gate placed on the lymphocyte cell 
population. How this is then represented is described in the 
following example: Jones et al. (2012) explored the expres-
sion patterns of T-plastin (PLS3) on Sézary cells. Single-color 
flow analysis was first used to distinguish the PLS3+ cells 
from the PLS3– cells, with the cell marker being measured on 
the X-axis and the number of counts on the Y-axis (Figure 4, 
Figure 3. Gating strategy to define lymphocyte subsets. (i) Histogram (univariate) plot of CD3 expression; this one-dimensional graph corresponds to a 
typical bar chart and is called “histogram” in flow cytometry. (ii) Pseudocolor plot of CD3 versus CD4. This display gives a better view on the distribution 
of CD3 expression than the histogram, in particular for **CD3 low expressing cells; note both axes are logarithmic, unlike the linear axes of scatter plots in 
Figure 2. (iii) Cartoon detailing interpretation of quadrant gates of (ii). CD3+CD4+ cells are displayed in the top right quadrant (46.2% of lymphocytes). CD, 
cluster of differentiation.
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bottom). They then “gated on,” or only allowed analysis of, 
the PLS3– cells (upper left) and then gated on the PLS3+ cells 
(upper right) and plotted both populations by CD3 by CD4 
fluorescence. This demonstrated that a diverse population 
existed within the PLS3– cells, most of which stained weakly 
for CD3 and CD4, but that there was also a separate popu-
lation that stained more strongly for CD3 and CD4, repre-
senting CD3+CD4+PLS3– Sézary cells. When only PLS3+ cells 
were examined (i.e., the CD3, CD4 plot gating on PLS3+ 
cells), most of them were CD3+CD4+, leading the authors to 
conclude that although PLS3+ may label a substantial subset 
of Sézary cells, some tumor cells will be missed if relying 
only on PLS3 staining. Figure 4 demonstrates another com-
mon convention in flow cytometry, which is either to show 
the percentage of a certain cell population with a line and a 
number, as in this figure, or to split the plots into quadrants or 
geometric shapes with an adjacent number representing the 
percentage of the total cell population delineated.
WhaT are The maJOr adVanTaGes and 
disadVanTaGes OF FlOW cYTOmeTrY, and hOW dOes 
iT cOmpare WiTh OTher Techniques?
Flow cytometry is the most important technology for generating 
correlative information about single cells within heteroge-
neous sample preparations and in a high-throughput fashion. 
Advances in technology and fluorophore chemistry allow for 
the rapid and quantitative measurement of up to 20 para meters 
of cell phenotype simultaneously in a highly sensitive and 
reproducible manner (De Rosa et al., 2001) The greatest advan-
tage of polychromatic flow cytometry is its high specificity for 
discrete cell subsets and rare populations, as demonstrated 
by Kagami et al. in their pivotal psoriasis study (Kagami et al., 
2010; see Figure 5). Rare cell subsets with frequencies as low 
as 0.01% (e.g., antigen-specific cytokine-producing cells) can 
be detected. In addition, flow cytometric cell sorting allows for 
isolation of cells of interest to very high purity.
Figure 5. Kagami et al. (2010) reported an increased frequency of Th17, Th22, and Th1 cells, specialized cd4+ Th lymphocytes producing il-17a, 
il-22, and iFn-γ, respectively, in untreated psoriasis patients compared with healthy controls using seven-color flow cytometry. The fluorescence 
plots are gated on CD4+ lymphocytes that have been stimulated for 6 hours with phorbol myristate acetate, followed by staining for IL-17A, interferon 
(IFN)-γ, and IL-22. Of note, most cells producing IL-22 do not produce IL-17A or IFN-γ at the same time: in the middle plot, a total of 3.2% of cells are 
positive for IL-22 staining (2.33% cells produce only IL-22 and not IFN-γ, whereas 0.87% produce both cytokines). Similarly, in the right fluorescein 
plot, a total of 3.27% of cells produce IL-22 (2.99% of cells are single positive for IL-22 and 1.25% are double positive for IL-22 and IL-17A). A similar 
observation can be made for IL-17A-producing cells. CD, cluster of differentiation; IL, interleukin; Th, T helper.
Figure 4. an example of gating in which the single-color flow analysis 
is shown with the X-axis labeled with the name of the fluorescently 
labeled cell marker, pls3, on a logarithmic scale and the number of 
counts of the marker on the Y-axis. Two cell populations are seen: 
one that is positive for PLS3 (on the right) and a second that is negative 
(on the left). The fluorescent by fluorescent dot plot on the upper left is 
“gated on”—or restricted to—those cells that were PLS3 negative and 
demonstrates a large group of heterogeneous cells with weak staining 
for CD3 and CD4 and a separate population with stronger CD3/CD4 
staining. In the upper right, PLS3+ cells are gated on and the CD3 by CD4 
fluorescent plot shows that most of the analyzed cells in that gate are 
CD3/CD4, although the CD3 is an order of magnitude higher than CD4. 
Taken together, this experiment demonstrated that the Sézary cells from 
this patient were mostly, but not all, PLS3+ (Jones et al., 2012). CD, cluster 
of differentiation; PLS3, T-plastin.
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Highly multiplex data can also be generated by genome-
wide transcriptional profiling (micorarray, RNAseq); how-
ever, these data do not allow for the distinction of signals on 
a single-cell basis. Likewise, various immunoblotting tech-
niques (such as western blot) and polymerase chain reaction 
use cellular lysates and do not provide information about 
single cells. Enzyme-linked immunosorbent assays measure 
soluble, and not cell-bound, markers.
WhaT are The maJOr limiTaTiOns OF This 
TechnOlOGY?
Cells must be in a single-cell suspension to be evaluated in 
a flow cytometer. Although this is not a problem for blood 
cells, tissues must be disrupted, which can affect cellular 
function. Also, information about tissue architecture is not 
available. The number of parameters per cell that can be mea-
sured simultaneously is limited by the number of detectors 
to less than two dozen, and, because of the spillover effect, 
only 6–12 color experiments are performed routinely in most 
laboratories (Roederer, 2001). Validation of results is required 
using the simultaneous detection of multiple markers to 
increase specificity or the analysis of stimulated cytokine pro-
duction of isolated cells to further confirm their phenotype. 
An important limitation to flow cytometry is a surprising lack 
of standardization in assay and instrument set-up; standards 
are also lacking in how flow data are analyzed and report-
ed, although numerous efforts have been launched recently 
(Maecker et al., 2010; Britten et al., 2011). Finally, because of 
the massive amount of data generated, flow data analysis can 
become very complicated and relies almost exclusively on 
gating by a human expert. Automated multidimensional visu-
alization and gating tools as well as postanalysis data aggre-
gation models for flow cytometry data (Qiu et al., 2011) are 
being developed to fill this gap.
summarY and FuTure direcTiOns
New developments aim to combine the advantages of flow 
cytometry (i.e., measuring multiple parameters on a single-
cell level) with transcriptional profiling or microscopy (imag-
ing flow cytometry) or to push into the realm of “single-cell 
proteomics” (Irish et al., 2006) by adding many more “detec-
tors” with mass spectroscopy. Cytometry by time of flight, or 
mass cytometry, employs time-of-flight mass spectrometry to 
discriminate a set of more than 40 heavy metal ion–labeled 
antibodies without the drawbacks of fluorescence spill-
over or autofluorescence (Bendall et al., 2011, 2012). The 
Fludigm Biomark system allows the quantification of mRNA 
levels using highly multiplexed real-time polymerase chain 
reaction using special microfluidic devices, thereby allow-
ing detection of up to more than 100 gene transcripts from a 
single cell (Bagwell, 2011).
Flow cytometry is a pivotal tool for the analysis of cell 
subsets and their complex interplay in immunological and 
biological processes. It has advanced our understanding of 
the immune system and is likely to play a fundamental role 
in the future in identifying biomarkers for disease progno-
sis or treatment response (“companion diagnostic tests”) and 
the development of individualized medicine.
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SUPPLEMENTARY MATERIAL
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QUESTIONS
1.  Side scatter (SSC) and forward scatter (FSC) provide 
information on ___________and _________, respectively.
 A. Tissue architecture, granularity
 B. Granularity, size
 C. Size, cell–cell interactions
 D. Cell-surface markers, intracellular signaling
2. “Gating” refers to:
 A.  The process of cells lining up single file before 
entering the laser path.
 B.  The field the cells enter during the sorting 
process.
 C.  The restriction of a portion of the analyzed cells 
for further analysis.
 D.  The overlapping fluorophore signals generated 
in flow experiments with many fluorophores.
3.  In a fluorescent by fluorescent scatter plot, cells 
present in the upper right quadrant of the plot are 
generally:
 A. Negative for one marker, positive for the other.
 B. Negative for both markers.
 C. Positive for aberrant marker expression.
 D. Positive for both markers.
Answers to the questions and an opportunity to comment on 
the article are available on our blog: http://blogs.nature.com/
jid_jottings/.
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